The fiscal year-end dividend for the term ending December 2025 is 147 yen per share (ordinary dividend 72 yen, 100th anniversary commemorative dividend 75 yen), raising the annual dividend to 272 yen. The total dividend amount is 241.92 billion yen, with an effective date of March 27, 2026.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4519","jir_company_name":"Chugai Pharmaceutical Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-01-29","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/01\/4519-20260129-03.pdf","jir_short_summary":"The fiscal year-end dividend for the term ending December 2025 is 147 yen per share (ordinary dividend 72 yen, 100th anniversary commemorative dividend 75 yen), raising the annual dividend to 272 yen. The total dividend amount is 241.92 billion yen, with an effective date of March 27, 2026.","jir_summary":"### Dividend Overview\nChugai Pharmaceutical Co., Ltd. has resolved a year-end dividend of 147 yen per share (ordinary dividend 72 yen, 100th anniversary commemorative dividend 75 yen) with the record date set on December 31, 2025, to be proposed at the 115th Annual General Meeting of Shareholders scheduled for March 26, 2026. This brings the annual dividend to 272 yen, with a total dividend payout of 241.92 billion yen. The dividend source is retained earnings.\n\n### Dividend Policy and Future Outlook\nThe company aims for a stable dividend policy targeting a dividend payout ratio averaging 45% relative to Core EPS. In fiscal 2025, Core net income marked its ninth consecutive year of growth, with Core EPS increasing 13.6% year-over-year. Based on this, the payout ratio reached 99.3% (five-year average 54.9%). The dividend forecast for 2026 is 132 yen annually (including an interim dividend of 66 yen), with an expected Core dividend payout ratio of 44.7% (five-year average 54.7%).","jir_financial_highlights":"Year-end Dividend per Share: 147 yen 00 sen (Year-over-Year increase of 90 yen (57 yen \u2192 147 yen))\nAnnual Dividend per Share: 272 yen 00 sen (Year-over-Year increase of 174 yen (98 yen \u2192 272 yen))\nTotal Dividend Amount: 241.92 billion yen (Unknown)","jir_category":"","jir_hashtags":"#ChugaiPharmaceuticalCoLtd, #DividendRelated, #JapaneseStocks","jir_key_figures":"Year-end Dividend per Share: 147 yen 00 sen (ordinary dividend 72 yen, 100th anniversary commemorative dividend 75 yen)\nAnnual Dividend per Share: 272 yen 00 sen (ordinary dividend 122 yen, 100th anniversary commemorative dividend 150 yen)\nTotal Dividend Amount: 241.92 billion yen","jir_meta_title":"Chugai Pharmaceutical Announces Significant Dividend Increase to 147 Yen Year-End and 272 Yen Annual for FY2025","jir_meta_description":"Chugai Pharmaceutical Co., Ltd. has resolved a year-end dividend of 147 yen per share (ordinary dividend 72 yen, commemorative dividend 75 yen) for the fiscal year ending December 2025. The annual dividend rises to 272 yen with a payout ratio reaching 99.3%.","jir_og_title":"Chugai Pharmaceutical Announces Major Dividend Increase for FY2025","jir_og_description":"Chugai Pharmaceutical raises the FY2025 year-end dividend to 147 yen and the annual dividend to 272 yen, maintaining its stable dividend policy.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":6836,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"dividend","footnotes":""},"sector":[],"importance":[],"class_list":["post-21931","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n